| 26th Nov 2024 7:00 am |
RNS |
Extended distribution agreement with Arthrex, Inc. |
| 25th Nov 2024 9:30 am |
RNS |
Form 8.5 (EPT/NON-RI) |
| 22nd Nov 2024 9:16 am |
RNS |
Form 8.5 (EPT/NON-RI) |
| 21st Nov 2024 9:22 am |
RNS |
Form 8.5 (EPT/NON-RI) |
| 20th Nov 2024 2:07 pm |
RNS |
Holding(s) in Company |
| 20th Nov 2024 11:16 am |
RNS |
Form 8.5 (EPT/NON-RI) |
| 20th Nov 2024 11:12 am |
RNS |
Form 8.3 - Tissue Regenix Group plc |
| 19th Nov 2024 8:38 am |
RNS |
Form 8.5 (EPT/NON-RI) |
| 18th Nov 2024 12:43 pm |
RNS |
Form 8.3 - Tissue Regenix Group PLC |
| 15th Nov 2024 8:45 am |
RNS |
Form 8.3 - Tissue Regenix Group plc |
| 14th Nov 2024 9:19 am |
RNS |
Form 8.5 (EPT/NON-RI) |
| 13th Nov 2024 9:32 am |
RNS |
Form 8.3 - Tissue Regenix Group Plc |
| 12th Nov 2024 4:05 pm |
RNS |
Form 8 (OPD) (Tissue Regenix Group Plc) |
| 12th Nov 2024 8:46 am |
RNS |
Form 8.5 (EPT/NON-RI) |
| 11th Nov 2024 9:17 am |
RNS |
Form 8.5 (EPT/NON-RI) |
| 7th Nov 2024 9:59 am |
RNS |
Form 8.5 (EPT/NON-RI) - Tissue Regenix Group PLC |
| 6th Nov 2024 1:37 pm |
RNS |
Form 8.3 - Tissue Regenix Group PLC |
| 6th Nov 2024 8:52 am |
RNS |
Form 8.5 (EPT/NON-RI) |
| 5th Nov 2024 2:24 pm |
RNS |
Form 8.3 - Tissue Regenix Group PLC |
| 5th Nov 2024 11:32 am |
RNS |
Form 8.5 (EPT/NON-RI) |
| 4th Nov 2024 4:36 pm |
RNS |
Response to media speculation |
| 10th Sep 2024 7:00 am |
RNS |
Interim results for the six months ended 30 June |
| 18th Jul 2024 3:52 pm |
RNS |
Grant of share options |
| 16th Jul 2024 7:00 am |
RNS |
Half-Year Trading Update |
| 3rd Jul 2024 1:16 pm |
RNS |
Holding(s) in Company |
| 24th Jun 2024 4:12 pm |
RNS |
Holding(s) in Company |
| 18th Jun 2024 5:15 pm |
RNS |
Exercise of Options, Director Dealing and TVR |
| 14th Jun 2024 7:00 am |
RNS |
Building purchase |
| 25th Apr 2024 2:27 pm |
RNS |
Result of AGM |
| 10th Apr 2024 7:15 am |
EQS |
Hardman & Co Research on Tissue Regenix (TRX): Six consecutive periods of >20% growth |
| 5th Apr 2024 3:52 pm |
RNS |
Holding(s) in Company |
| 19th Mar 2024 7:00 am |
RNS |
Final results for the year ended 31 December 2023 |
| 1st Mar 2024 7:00 am |
RNS |
Notice of Results |
| 6th Feb 2024 7:00 am |
RNS |
First EU shipment & new distributor agreements |
| 29th Jan 2024 3:02 pm |
RNS |
Holding(s) in Company |
| 25th Jan 2024 7:00 am |
RNS |
Trading update for 2023 |
| 23rd Jan 2024 5:24 pm |
RNS |
2023 LTIP Grant |
| 22nd Nov 2023 4:36 pm |
RNS |
Holding(s) in Company |
| 30th Oct 2023 7:00 am |
RNS |
HPRA approval & distribution agreement in Spain |
| 18th Sep 2023 10:40 am |
EQS |
Hardman & Co Research on Tissue Regenix (TRX): Continuing postive momentum 1H'23 |
